| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |